Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

MANAGEMENT OF DIABETES DURING AIR TRAVEL: A SYSTEMATIC LITERATURE REVIEW OF CURRENT RECOMMENDATIONS AND THEIR SUPPORTING EVIDENCE.

Pavela J, Suresh R, Blue RS, Mathers CH, Belalcazar LM.

Endocr Pract. 2018 Feb;24(2):205-219. doi: 10.4158/EP171954.RA. Review.

PMID:
29466062
2.

Looking Back at Look AHEAD Through the Lens of Recent Diabetes Outcome Trials.

Belalcazar LM, Ballantyne CM.

Circulation. 2017 Feb 21;135(8):720-723. doi: 10.1161/CIRCULATIONAHA.116.024627. Review. No abstract available.

3.

Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD.

Belalcazar LM, Papandonatos GD, Erar B, Peter I, Alkofide H, Balasubramanyam A, Brautbar A, Kahn SE, Knowler WC, Ballantyne CM, McCaffery JM, Huggins GS; Genetics Subgroup of the Look AHEAD Study*.

Circ Cardiovasc Genet. 2016 Feb;9(1):71-8. doi: 10.1161/CIRCGENETICS.115.001192. Epub 2015 Nov 17.

4.

Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD.

Belalcazar LM, Lang W, Haffner SM, Schwenke DC, Kriska A, Balasubramanyam A, Hoogeveen RC, Pi-Sunyer FX, Tracy RP, Ballantyne CM; Look AHEAD (Action for Health in Diabetes) Research Group.

Diabetes Care. 2015 Aug;38(8):1544-50. doi: 10.2337/dc14-2775. Epub 2015 May 13.

6.

A common variant in the CLDN7/ELP5 locus predicts adiponectin change with lifestyle intervention and improved fitness in obese individuals with diabetes.

Belalcazar LM, Papandonatos GD, McCaffery JM, Peter I, Pajewski NM, Erar B, Allred ND, Balasubramanyam A, Bowden DW, Brautbar A, Pi-Sunyer FX, Ballantyne CM, Huggins GS; Look AHEAD Research Group.

Physiol Genomics. 2015 Jun;47(6):215-24. doi: 10.1152/physiolgenomics.00109.2014. Epub 2015 Mar 10.

7.

Fiber intake and plasminogen activator inhibitor-1 in type 2 diabetes: Look AHEAD (Action for Health in Diabetes) trial findings at baseline and year 1.

Belalcazar LM, Anderson AM, Lang W, Schwenke DC, Haffner SM, Yatsuya H, Rushing J, Vitolins MZ, Reeves R, Pi-Sunyer FX, Tracy RP, Ballantyne CM; Look AHEAD (Action for Health in Diabetes) Research Group.

J Acad Nutr Diet. 2014 Nov;114(11):1800-10.e2. doi: 10.1016/j.jand.2014.06.357. Epub 2014 Aug 15.

8.

Genetic modifiers of cardiorespiratory fitness response to lifestyle intervention.

Peter I, Papandonatos GD, Belalcazar LM, Yang Y, Erar B, Jakicic JM, Unick JL, Balasubramanyam A, Lipkin EW, Delahanty LM, Wagenknecht LE, Wing RR, McCaffery JM, Huggins GS; Look AHEAD Research Group.

Med Sci Sports Exerc. 2014 Feb;46(2):302-11. doi: 10.1249/MSS.0b013e3182a66155.

9.

Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: The Action for Health in Diabetes (Look AHEAD) study.

Huggins GS, Papandonatos GD, Erar B, Belalcazar LM, Brautbar A, Ballantyne C, Kitabchi AE, Wagenknecht LE, Knowler WC, Pownall HJ, Wing RR, Peter I, McCaffery JM; Genetics Subgroup of the Action for Health in Diabetes (Look AHEAD) Study.

Circ Cardiovasc Genet. 2013 Aug;6(4):391-9. doi: 10.1161/CIRCGENETICS.113.000042. Epub 2013 Jul 16.

10.

Comment on: Cohen et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012;35:1420-1428.

Thukunthla S, Belalcazar LM.

Diabetes Care. 2013 Jun;36(6):e79. doi: 10.2337/dc12-2244. No abstract available.

11.

Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study.

Belalcazar LM, Haffner SM, Lang W, Hoogeveen RC, Rushing J, Schwenke DC, Tracy RP, Pi-Sunyer FX, Kriska AM, Ballantyne CM; Look AHEAD (Action for Health in Diabetes) Research Group.

Obesity (Silver Spring). 2013 May;21(5):944-50. doi: 10.1002/oby.20431.

12.

Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study.

Belalcazar LM, Lang W, Haffner SM, Hoogeveen RC, Pi-Sunyer FX, Schwenke DC, Balasubramanyam A, Tracy RP, Kriska AP, Ballantyne CM; Look AHEAD Research Group.

J Lipid Res. 2012 Dec;53(12):2726-33. doi: 10.1194/jlr.M030213. Epub 2012 Sep 5.

13.

The effect of various intensities of physical activity and chronic inflammation in men and women by diabetes status in a national sample.

Hawkins M, Belalcazar LM, Schelbert KB, Richardson C, Ballantyne CM, Kriska A.

Diabetes Res Clin Pract. 2012 Jul;97(1):e6-8. doi: 10.1016/j.diabres.2012.03.019. Epub 2012 Apr 15.

PMID:
22510300
14.

Nutrition and metabolism--sphingolipids and branched chain amino acids: indicators and effectors of adipose tissue function and diabetes risk.

Belalcazar LM, Ballantyne CM.

Curr Opin Lipidol. 2011 Dec;22(6):503-4. doi: 10.1097/MOL.0b013e32834d1716. No abstract available.

PMID:
22101560
15.

Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study.

Belalcazar LM, Ballantyne CM, Lang W, Haffner SM, Rushing J, Schwenke DC, Pi-Sunyer FX, Tracy RP; Look Action for Health in Diabetes Research Group.

Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1689-95. doi: 10.1161/ATVBAHA.111.224386. Epub 2011 Apr 21.

16.

Evaluating if patient self-perceptions of competencies have an influence on biological indicators for cardio-metabolic health.

Clark MC, Nguyen H, Belalcazar LM.

Diabetes Res Clin Pract. 2011 Apr;92(1):e3-6. doi: 10.1016/j.diabres.2010.12.008. Epub 2011 Jan 11.

PMID:
21227529
17.

A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study.

Belalcazar LM, Reboussin DM, Haffner SM, Hoogeveen RC, Kriska AM, Schwenke DC, Tracy RP, Pi-Sunyer FX, Ballantyne CM; Look AHEAD Research Group.

Diabetes Care. 2010 Nov;33(11):2297-303. doi: 10.2337/dc10-0728. Epub 2010 Aug 3.

18.

Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study.

Belalcazar LM, Reboussin DM, Haffner SM, Reeves RS, Schwenke DC, Hoogeveen RC, Pi-Sunyer FX, Ballantyne CM; Look AHEAD (Action for Health in Diabetes) Obesity, Inflammation, and Thrombosis Research Group.

Diabetes Care. 2010 Jan;33(1):197-9. doi: 10.2337/dc09-1235. Epub 2009 Oct 19.

19.

Statin-induced diabetes: will it change clinical practice?

Belalcazar LM, Raghavan VA, Ballantyne CM.

Diabetes Care. 2009 Oct;32(10):1941-3. doi: 10.2337/dc09-1277. No abstract available.

20.
21.

Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.

Oka K, Belalcazar LM, Dieker C, Nour EA, Nuno-Gonzalez P, Paul A, Cormier S, Shin JK, Finegold M, Chan L.

Gene Ther. 2007 Feb;14(3):191-202. Epub 2006 Sep 7. Erratum in: Gene Ther. 2007 May;14(10):845.

22.

Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression.

Cowey SL, Quast M, Belalcazar LM, Wei J, Deng X, Given R, Singh P.

Cancer. 2005 Jun 15;103(12):2643-53.

23.

Aortic eNOS expression and phosphorylation in Apo-E knockout mice: differing effects of rapamycin and simvastatin.

Naoum JJ, Zhang S, Woodside KJ, Song W, Guo Q, Belalcazar LM, Hunter GC.

Surgery. 2004 Aug;136(2):323-8.

PMID:
15300198
24.

Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway.

Recinos A 3rd, Carr BK, Bartos DB, Boldogh I, Carmical JR, Belalcazar LM, Brasier AR.

Physiol Genomics. 2004 Sep 16;19(1):131-42. Epub 2004 Jul 6.

PMID:
15238619
25.

Hepatitis C: a metabolic liver disease.

Weinman SA, Belalcazar LM.

Gastroenterology. 2004 Mar;126(3):917-9. Review. No abstract available.

PMID:
14988846
26.

Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.

Pastore L, Belalcazar LM, Oka K, Cela R, Lee B, Chan L, Beaudet AL.

Gene. 2004 Mar 3;327(2):153-60.

PMID:
14980712
27.
28.

Visual vignette. Cushing's syndrome due to ectopic production of ACTH by a bronchial carcinoid.

Szymajda A, Eledrisi MS, Lieberman S, Belalcazar LM, Schnadig V.

Endocr Pract. 2001 Nov-Dec;7(6):492. No abstract available.

PMID:
11770489
29.

Defining specific goals of therapy in treating dyslipidemia in the patient with low high-density lipoprotein cholesterol.

Belalcazar LM, Ballantyne CM.

Prog Cardiovasc Dis. 1998 Sep-Oct;41(2):151-74. Review.

PMID:
9790415

Supplemental Content

Loading ...
Support Center